McKesson: The Invisible Titan of Medicine

Explore the 190-year history of McKesson, the healthcare giant behind one-third of North America’s medicine and some of history's biggest corporate scandals.[INTRO]ALEX: If you’ve taken a prescription pill in the last twenty-four hours, there is a one-in-three chance it passed through the hands of a single company you’ve probably never thought about. It’s called McKesson, and they are the Fortune 10 giant that acts as the invisible logistical backbone of American healthcare.JORDAN: Wait, Fortune 10? Like, bigger than Google or Exxon? Why haven't I heard of them if they’re moving a third of the continent's drugs?ALEX: Exactly. They are the ultimate middleman, a company that has survived for nearly 200 years by being indispensable. But behind that efficiency lies a history of massive fraud, a role in the opioid crisis, and a scandal so big it literally changed how every company in America does their accounting.[CHAPTER 1 - Origin]ALEX: The story starts in 1833 in New York City. Two guys, John McKesson and Charles Olcott, opened a small shop to import and wholesale botanical drugs and chemicals. This was the Wild West of medicine—herbs, tinctures, and raw chemicals sold to a growing nation.JORDAN: So they were basically the neighborhood drug wholesale guys? How does that turn into a global behemoth?ALEX: Well, they were obsessed with quality and scale. By 1853, after Olcott passed away, Daniel Robbins joined, and the legendary name 'McKesson & Robbins' was born. They weren't just selling potions anymore; they were manufacturing pharmaceuticals and winning awards for purity at the Centennial Exposition in 1876.JORDAN: Okay, so they were the gold standard early on. But how did they go from a NYC shop to a national network?ALEX: That happened in 1928. A man named Frank Seiberling—the guy who founded Goodyear Tire—acquired McKesson and merged it with fourteen other regional wholesalers. Suddenly, they weren't just a supplier; they were a national infrastructure. But right as they reached the top, they realized their president wasn't who he said he was.[CHAPTER 2 - Core Story]JORDAN: A fake president? That sounds like a movie plot. What actually happened?ALEX: It’s one of the most bizarre frauds in history. The company president, F. Donald Coster, was actually Philip Musica—a convicted felon and con artist. He created a fictional Canadian subsidiary and used it to inflate the company’s assets by about twenty-one million dollars.JORDAN: Twenty-one million in the 1930s? That's hundreds of millions today! How did he fake an entire branch of the company?ALEX: He invented paper inventory and fake accounts receivable. He was basically trading with a ghost. When the board got suspicious in 1938 and the police closed in, Musica took his own life. The scandal was so massive it forced the creation of modern auditing rules. Before this, auditors didn't actually have to physically check if inventory existed. Because of McKesson, 'seeing is believing' became the law for American business.JORDAN: So they almost died in the 30s, they survived, but you mentioned this happened again?ALEX: Remarkably, yes. In 1999, McKesson bought a healthcare tech company called HBOC for fourteen billion dollars. Almost immediately after the ink dried, they discovered HBOC had been cooking their books for years. McKesson’s stock price crashed fifty percent in a single day, erasing nine billion dollars in value. JORDAN: This company has a serious habit of walking into financial landmines. How do they keep surviving? ALEX: Resilience and necessity. They've spent decades acquiring competitors and expanding. By the 2010s, they weren't just moving pills; they were a global logistics powerhouse. But that scale became a curse during the opioid epidemic. As one of the 'Big Three' distributors, they were sued for failing to report suspicious, massive orders of painkillers to small-town pharmacies.JORDAN: Right, because as the middleman, they’re the ones who see the red flags first. Did they actually pay for it?ALEX: They did. Between 2017 and 2022, they paid out billions in settlements, including a landmark seven-point-nine billion dollar deal to settle claims from state and local governments. It’s a recurring theme: they provide a vital service, but the pressure for profit sometimes blinds the gatekeepers.[CHAPTER 3 - Why It Matters]JORDAN: So they're the company that is 'too big to fail' but also 'too essential to ignore.' What does their world look like now?ALEX: Today, McKesson has pivoted. They sold off most of their European business to focus on North America, specifically high-growth areas like cancer treatment and specialty drugs. And if you want to see them at their best, look at the COVID-19 pandemic. JORDAN: They were involved in the vaccine rollout, right?ALEX: They were the centralized distributor for the Moderna and Johnson & Johnson vaccines in the U.S. They managed the entire cold-chain logistics—keeping millions of doses at sub-zero temperatures and getting them to every corner of the country. It was a masterclass in why we need a company with their specific, massive scale.JORDAN: It’s like they are the heart of the medical system—if they stop pumping, everything dies, even if the heart itself has had a few scandals over the years.ALEX: Exactly. They are the definition of an 'invisible giant.' They operate behind the scenes of every hospital and pharmacy, managing the complexity so we don't have to.[OUTRO]JORDAN: All right, Alex, give it to me: what’s the one thing we should remember about McKesson?ALEX: McKesson is the essential but controversial engine of healthcare that turned its own massive scandals into the very rules that govern modern American accounting.JORDAN: That's Wikipodia — every story, on demand. Search your next topic at wikipodia.ai